Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-19

Clinical Trial Update: Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating targeted zinc fortification programs and their effect on plasma zinc concentrations in individuals with zinc deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZINC (Zinc chloride)

Snippet

Sponsor: University of California, Davis | Conditions: Zinc Deficiency | Phase 4 | Status: COMPLETED